PURA - Puration Confirms Spinoff Scheduled Next Week and Announces New Target Cannabis Beverage Acquisition
29 September 2018 - 1:51AM
InvestorsHub NewsWire
PURA - Puration Confirms Spinoff
Scheduled Next Week and Announces New Target Cannabis Beverage
Acquisition
Dallas, TX -- September 28, 2018 --
InvestorsHub NewsWire -- Puration,
Inc. (USOTC:
PURA) (“PURA”) today confirmed the company plans to
execute a definitive transaction by next Thursday, the
6th of October with Nouveau Life Pharmaceuticals, Inc.,
(USOTC:
NOUV) (“NOUV”). The transaction is designed to affect a
“spinoff” of PURA’s cannabis cultivation business with shares of
NOUV being issued to PURA shareholders in a stock dividend.
The spinoff is part of a strategy for PURA to focus all resources
on expanding
its cannabis infused beverage business. PURA introduced
EVERx CBD Sports Water last year and company sales have since
increased 600%. In addition to expanding and growing its
cannabis beverage business organically, PURA plans to acquire
additional beverage businesses as well. Today the company is
announcing a first target acquisition is in the works. The
target acquisition is anticipated to be announced shortly after the
closing of the spinoff transaction.
Learn
more about Puration at www.purationinc.com
Learn more about the
cultivation business at https://www.purationinc.com/extraction
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2024 to May 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Puration Inc (CE) (OTCMarkets): 0 recent articles
More Puration Inc. (PC) News Articles